Atlas Clinical Research Acquires Suburban Research Associates
July 12, 2023
Atlas Clinical Research, a therapeutically-driven clinical site network and portfolio company of healthcare investor BPOC, has added Suburban Research Associates — a two-location psychiatric clinical research site in Media and West Chester, Pennsylvania — to its platform. The partnership will expand Atlas's site network and give Suburban access to centralized technology, operational support and broader sponsor/CRO connectivity to accelerate psychiatric clinical trials and patient reach.
- Buyers
- Atlas Clinical Research
- Targets
- Suburban Research Associates
- Sellers
- Dr. Shivkumar Hatti
- Platforms
- Atlas Clinical Research
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
ENT Partners Acquires Suburban Otolaryngology
November 18, 2021
Healthcare Services
ENT Partners, a physician practice management company focused on ENT practices, has acquired Suburban Otolaryngology in Berwyn, Illinois. The deal expands ENT Partners' Chicagoland footprint and strengthens relationships with regional health systems including Rush University Medical Center and Loyola Medicine.
-
BPOC and PNC Erieview Invest in Atlas Clinical Research to Acquire Rochester Clinical Research
April 25, 2023
Healthcare Services
BPOC launched Atlas Clinical Research, a therapeutically-driven clinical research site platform, and acquired Rochester Clinical Research (RCR) as the foundational site. PNC Erieview Capital provided an equity co-investment alongside BPOC; Oxford Finance provided debt financing and legal/financial advisors supported the transaction.
-
Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Healthcare Services
Adams Clinical has agreed to acquire InSite Clinical Research, a Dallas–Fort Worth clinical trial site specializing in inpatient and outpatient psychiatric and neurologic trials, expanding Adams' capabilities into inpatient psychiatry and Schizophrenia trials. The deal adds a Texas footprint for Adams and follows Adams' broader 2024 expansion; InTandem Capital Partners (Adams' investor) commented on the partnership.
-
Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Healthcare Services
Adams Clinical, a neuroscience-focused clinical trial site network, has agreed to acquire/partner with InSite Clinical Research to add inpatient and schizophrenia clinical trial capabilities and expand into Texas. The deal will also enable Adams to establish inpatient units at its Watertown, MA and Bronx, NY sites; Provident Healthcare Partners served as exclusive financial advisor to InSite.
-
PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
Healthcare Services
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
-
Alcanza Clinical Research Acquires Charlottesville Medical Research
September 6, 2022
Healthcare Services
Alcanza Clinical Research has acquired Charlottesville Medical Research, adding the Charlottesville, Virginia community-based clinical research site to its integrated investigator site network. The deal expands Alcanza’s geographic reach and inclusive research capabilities to improve access to Phase II-IV trials for under-represented patient populations.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.